Calpains and proteasomes mediate degradation of ryanodine receptors in a model of cardiac ischemic reperfusion

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 3, 2010, Pages 356-362

  Pedrozo, Zully ^a   Sánchez, Gina ^a   Torrealba, Natalia ^a,b   Valenzuela, Rodrigo ^a,b   Fernández, Carolina ^a   Hidalgo, Cecilia ^a   Lavandero, Sergio ^a,b   Donoso, Paulina ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Calcium release channel; Calpastatin; Neonatal cardiomyocyte; Protease; Protein degradation; Sarcoplasmic reticulum

Indexed keywords

BECLIN 1; CALPAIN; CALPASTATIN; CELL PROTEIN; MESSENGER RNA; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN LC3 II; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DISEASE SIMULATION; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; CALPAIN; IMMUNOENZYME TECHNIQUES; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

ADENOVIRIDAE; RATTUS;

EID: 74849086236     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2009.12.005     Document Type: Article

References (51)

1. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 357 (2007) 1121-1135
2. Chohan P.K., Singh R.B., Dhalla N.S., and Netticadan T. l-arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation. Cardiovasc. Res. 69 (2006) 152-163
3. Singh R.B., Chohan P.K., Dhalla N.S., and Netticadan T. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J. Mol. Cell. Cardiol. 37 (2004) 101-110
4. Powell S.R., Wang P., Katzeff H., Shringarpure R., Teoh C., Khaliulin I., Das D.K., Davies K.J., and Schwalb H. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid. Redox Signal. 7 (2005) 538-546
5. Temsah R.M., Netticadan T., Chapman D., Takeda S., Mochizuki S., and Dhalla N.S. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am. J. Physiol. 277 (1999) H584-H594
6. Takeda S., Mochizuki S., Saini H.K., Elimban V., and Dhalla N.S. Modification of alterations in cardiac function and sarcoplasmic reticulum by vanadate in ischemic-reperfused rat hearts. J. Appl. Physiol. 99 (2005) 999-1005
7. An J., Bosnjak Z.J., and Jiang M.T. Myocardial protection by isoflurane preconditioning preserves Ca2+ cycling proteins independent of sarcolemmal and mitochondrial KATP channels. Anesth. Analg. 105 (2007) 1207-1213 (table of contents)
8. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88 (2008) 581-609
9. Domenech R.J., Sanchez G., Donoso P., Parra V., and Macho P. Effect of tachycardia on myocardial sarcoplasmic reticulum and Ca2+ dynamics: a mechanism for preconditioning?. J. Mol. Cell. Cardiol. 35 (2003) 1429-1437
10. Zucchi R., Ronca F., and Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection?. Pharmacol. Ther. 89 (2001) 47-65
11. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
12. Meijer A.J., and Codogno P. Regulation and role of autophagy in mammalian cells. Int. J. Biochem. Cell Biol. 36 (2004) 2445-2462
13. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., Yang G., Matsui Y., Sadoshima J., and Vatner S.F. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. USA 102 (2005) 13807-13812
14. Kiffin R., Bandyopadhyay U., and Cuervo A.M. Oxidative stress and autophagy. Antioxid. Redox Signal. 8 (2006) 152-162
15. Patterson C., and Cyr D. Welcome to the machine: a cardiologist's introduction to protein folding and degradation. Circulation 106 (2002) 2741-2746
16. Powell S.R. The ubiquitin-proteasome system in cardiac physiology and pathology. Am. J. Physiol. 291 (2006) H1-H19
17. Foncea R., Andersson M., Ketterman A., Blakesley V., Sapag-Hagar M., Sugden P.H., LeRoith D., and Lavandero S. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J. Biol. Chem. 272 (1997) 19115-19124
18. Li R.K., Mickle D.A., Weisel R.D., Zhang J., and Mohabeer M.K. In vivo survival and function of transplanted rat cardiomyocytes. Circ. Res. 78 (1996) 283-288
19. Diaz R.J., and Wilson G.J. Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc. Res. 70 (2006) 286-296
20. Okamura T., Taniguchi S., Ohkura T., Yoshida A., Shimizu H., Sakai M., Maeta H., Fukui H., Ueta Y., Hisatome I., and Shigemasa C. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. J. Clin. Endocrinol. Metab. 88 (2003) 1374-1383
21. Dong C., Upadhya S.C., Ding L., Smith T.K., and Hegde A.N. Proteasome Inhibition Enhances the Induction and Impairs the Maintenance of Late-Phase Long-Term Potentiation. Learning & Memory vol. 15 (2008), Cold Spring Harbor, N.Y. 335-347
22. Hamacher-Brady A., Brady N.R., and Gottlieb R.A. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281 (2006) 29776-29787
23. Criollo A., Galluzzi L., Maiuri M.C., Tasdemir E., Lavandero S., and Kroemer G. Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis 12 (2007) 3-18
24. Hartree E.F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 48 (1972) 422-427
25. Robin E., Guzy R.D., Loor G., Iwase H., Waypa G.B., Marks J.D., Hoek T.L., and Schumacker P.T. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J. Biol. Chem. 282 (2007) 19133-19143
26. Inserte J., Garcia-Dorado D., Ruiz-Meana M., Agullo L., Pina P., and Soler-Soler J. Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc. Res. 64 (2004) 105-114
27. French J.P., Quindry J.C., Falk D.J., Staib J.L., Lee Y., Wang K.K., and Powers S.K. Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am. J. Physiol. 290 (2006) H128-H136
28. Smith I.J., and Dodd S.L. Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp. Physiol. 92 (2007) 561-573
29. Hanna R.A., Campbell R.L., and Davies P.L. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 456 (2008) 409-412
30. Khalil P.N., Neuhof C., Huss R., Pollhammer M., Khalil M.N., Neuhof H., Fritz H., and Siebeck M. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model. Eur. J. Pharmacol. 528 (2005) 124-131
31. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., Levine B., and Sadoshima J. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100 (2007) 914-922
32. Matsui Y., Kyoi S., Takagi H., Hsu C.P., Hariharan N., Ago T., Vatner S.F., and Sadoshima J. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 4 (2008) 409-415
33. Tatsumi T., Shiraishi J., Keira N., Akashi K., Mano A., Yamanaka S., Matoba S., Fushiki S., Fliss H., and Nakagawa M. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 59 (2003) 428-440
34. Rardon D.P., Cefali D.C., Mitchell R.D., Seiler S.M., Hathaway D.R., and Jones L.R. Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release channel. Circ. Res. 67 (1990) 84-96
35. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., and Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J. Biol. Chem. 276 (2001) 30057-30063
36. Gurusamy N., Goswami S., Malik G., and Das D.K. Oxidative injury induces selective rather than global inhibition of proteasomal activity. J. Mol. Cell. Cardiol. 44 (2008) 419-428
37. Miranda M., and Sorkin A. Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms. Mol. Interv. 7 (2007) 157-167
38. Mearini G., Schlossarek S., Willis M.S., and Carrier L. The ubiquitin-proteasome system in cardiac dysfunction. Biochim. Biophys. Acta 1782 (2008) 749-763
39. Divald A., and Powell S.R. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic. Biol. Med. 40 (2006) 156-164
40. Enns D., Karmazyn M., Mair J., Lercher A., Kountchev J., and Belcastro A. Calpain, calpastatin activities and ratios during myocardial ischemia-reperfusion. Mol. Cell. Biochem. 241 (2002) 29-35
41. Doumit M.E., and Koohmaraie M. Immunoblot analysis of calpastatin degradation: evidence for cleavage by calpain in postmortem muscle. J. Anim. Sci. 77 (1999) 1467-1473
42. Kubalova Z., Terentyev D., Viatchenko-Karpinski S., Nishijima Y., Gyorke I., Terentyeva R., da Cunha D.N., Sridhar A., Feldman D.S., Hamlin R.L., Carnes C.A., and Gyorke S. Abnormal intrastore calcium signaling in chronic heart failure. Proc. Natl. Acad. Sci. USA 102 (2005) 14104-14109
43. Seki S., Nagashima M., Yamada Y., Tsutsuura M., Kobayashi T., Namiki A., and Tohse N. Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes. Cardiovasc. Res. 58 (2003) 535-548
44. Korhonen T., Hanninen S.L., and Tavi P. Model of excitation-contraction coupling of rat neonatal ventricular myocytes. Biophys. J. 96 (2009) 1189-1209
45. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
46. Valdivia C., Hegge J.O., Lasley R.D., Valdivia H.H., and Mentzer R. Ryanodine receptor dysfunction in porcine stunned myocardium. Am. J. Physiol. 273 (1997) H796-H804
47. Kim S.J., Kudej R.K., Yatani A., Kim Y.K., Takagi G., Honda R., Colantonio D.A., Van Eyk J.E., Vatner D.E., Rasmusson R.L., and Vatner S.F. A novel mechanism for myocardial stunning involving impaired Ca(2+) handling. Circ. Res. 89 (2001) 831-837
48. Dibb K.M., Graham H.K., Venetucci L.A., Eisner D.A., and Trafford A.W. Analysis of cellular calcium fluxes in cardiac muscle to understand calcium homeostasis in the heart. Cell Calcium 42 (2007) 503-512
49. Bodi I., Mikala G., Koch S.E., Akhter S.A., and Schwartz A. The L-type calcium channel in the heart: the beat goes on. J. Clin. Invest. 115 (2005) 3306-3317
50. Maekawa A., Lee J.K., Nagaya T., Kamiya K., Yasui K., Horiba M., Miwa K., Uzzaman M., Maki M., Ueda Y., and Kodama I. Overexpression of calpastatin by gene transfer prevents troponin I degradation and ameliorates contractile dysfunction in rat hearts subjected to ischemia/reperfusion. J. Mol. Cell. Cardiol. 35 (2003) 1277-1284
51. Luss H., Schmitz W., and Neumann J. A proteasome inhibitor confers cardioprotection. Cardiovasc. Res. 54 (2002) 140-151